BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.71B |
| 2 |
Alibaba
BABA
|
+$2.19B |
| 3 |
Truist Financial
TFC
|
+$2.16B |
| 4 |
iShares MBS ETF
MBB
|
+$841M |
| 5 |
ServiceNow
NOW
|
+$829M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$5.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$2.34B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$983M |
| 4 |
VIAB
Viacom Inc. Class B
VIAB
|
+$684M |
| 5 |
Apple
AAPL
|
+$623M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Financials | 14.42% |
| 3 | Healthcare | 13.59% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
LeMaitre Vascular
LMAT
$1.86B
| $94.1M | ﹤0.01% |
2,618,648
+64,312
| +3% | +$2.22M |
|
|
RC
2002
Ready Capital
RC
$308M
| $94M | ﹤0.01% |
6,097,111
+3,045,425
| +100% | +$48M |
|
|
ATSG
2003
DELISTED
Air Transport Services Group
ATSG
| $93.9M | ﹤0.01% |
4,001,049
+10,221
| +0.3% | +$229K |
|
2004
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.4B
| $93.9M | ﹤0.01% |
3,173,007
+638,039
| +25% | +$18.6M |
|
2005
Magnolia Oil & Gas
MGY
$5.94B
| $93.5M | ﹤0.01% |
7,431,305
-11,936
| -0.2% | -$134K |
|
2006
Helios Technologies
HLIO
$2.76B
| $93.4M | ﹤0.01% |
2,019,820
+3,012
| +0.1% | +$129K |
|
2007
BridgeBio Pharma
BBIO
$16.5B
| $93.2M | ﹤0.01% |
2,659,723
+1,184,951
| +80% | +$32.8M |
|
2008
Lakeland Financial Corp
LKFN
$1.53B
| $93.2M | ﹤0.01% |
1,904,896
-2,394
| -0.1% | -$111K |
|
2009
Myers Industries
MYE
$1.29B
| $93.2M | ﹤0.01% |
5,587,513
+246,767
| +5% | +$4.11M |
|
|
ECHO
2010
DELISTED
Echo Global Logistics, Inc.
ECHO
| $92.7M | ﹤0.01% |
4,480,531
+180,212
| +4% | +$3.76M |
|
2011
Appian
APPN
$2.48B
| $92.7M | ﹤0.01% |
2,427,029
+289,341
| +14% | +$12.5M |
|
|
CBPX
2012
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
| $92.7M | ﹤0.01% |
2,544,331
-156,970
| -6% | -$5.16M |
|
2013
TechTarget
TTGT
$278M
| $92.7M | ﹤0.01% |
3,550,108
+172,427
| +5% | +$4.38M |
|
2014
CEVA Inc
CEVA
$1.08B
| $92.2M | ﹤0.01% |
3,420,042
+112,075
| +3% | +$3.06M |
|
2015
Quanex
NX
$1.01B
| $92.1M | ﹤0.01% |
5,394,044
+131,716
| +3% | +$2.48M |
|
2016
Hanmi Financial
HAFC
$946M
| $92M | ﹤0.01% |
4,600,407
+58,844
| +1% | +$1.14M |
|
|
ERUS
2017
DELISTED
iShares MSCI Russia ETF
ERUS
| $91.9M | ﹤0.01% |
2,155,376
-2,235,901
| -51% | -$92.7M |
|
2018
Ubiquiti
UI
$34.3B
| $91.9M | ﹤0.01% |
486,108
-188,102
| -28% | -$30.3M |
|
|
NSTG
2019
DELISTED
NanoString Technologies, Inc.
NSTG
| $91.8M | ﹤0.01% |
3,300,087
-23,888
| -0.7% | -$580K |
|
2020
MYR Group
MYRG
$5.25B
| $91.7M | ﹤0.01% |
2,814,045
+119,258
| +4% | +$3.94M |
|
2021
iShares MSCI United Kingdom ETF
EWU
$4.16B
| $91.6M | ﹤0.01% |
2,687,200
+488,739
| +22% | +$15.9M |
|
2022
PUT
iShares MSCI Emerging Markets ETF
EEM
$30B
| $91.6M | ﹤0.01% |
+2,041,400
| New | +$87.6M |
|
2023
Karyopharm Therapeutics
KPTI
$48M
| $91.4M | ﹤0.01% |
317,928
+4,759
| +2% | +$1.03M |
|
2024
Denali Therapeutics
DNLI
$3.97B
| $91.4M | ﹤0.01% |
5,247,578
+669
| +0% | +$11.1K |
|
2025
Yeti Holdings
YETI
$3.95B
| $91.3M | ﹤0.01% |
2,625,768
+682,212
| +35% | +$21.5M |
|
Similar funds
BlackRock's Q4 2019 Portfolio in Review
As of Q4 2019, BlackRock held 5,193 positions worth $2.61T, up 9.5% from $2.38T the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock's Q4 2019 filing shows 167 new, 2,887 increased, 1,450 reduced and 161 closed positions. Its largest new stake was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M. The largest sale was Celgene Corp, an estimated $5.15B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- BlackRock's largest Q4 2019 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M.
- BlackRock added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.71B increase.
- BlackRock's biggest Q4 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $983M.
- BlackRock fully exited Celgene Corp in Q4 2019, selling an estimated $5.15B.
- BlackRock's ten largest holdings make up 15% of its $2.61T portfolio in Q4 2019.
- BlackRock opened 167 new positions and closed 161 in Q4 2019.
- BlackRock's portfolio value rose 9.5% quarter-over-quarter to $2.61T.
Based on BlackRock's 13F filing for Q4 2019, filed 13 Feb 2020.